Autosomal dominant polycystic kidney disease: genes and variants
Explore variant evidence for Autosomal dominant polycystic kidney disease across 3 analyzed proteins (PKD2, PKD1, AVPR2). Linked ClinVar records include 12 pathogenic or likely pathogenic variants, 356 variants of uncertain significance and 33 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Autosomal dominant polycystic kidney disease
PKD2: Polycystin-2
It provides calcium-permeable polycystin channel activity and forms signaling complexes with polycystin-1 in renal epithelial cells. Loss-of-function variants cause autosomal dominant polycystic kidney disease, generally with a milder average course than PKD1-associated disease.
6 ClinVar pathogenic / likely pathogenic and 359 uncertain variants in PKD2 have source records linked to Autosomal dominant polycystic kidney disease. Association strength is not clinical gene validity.
PKD1: Polycystin-1
Together with polycystin-2, it participates in tubular signaling, mechanosensation, and maintenance of renal epithelial architecture. Loss-of-function variants are the most common cause of autosomal dominant polycystic kidney disease.
6 ClinVar pathogenic / likely pathogenic and 30 uncertain variants in PKD1 have source records linked to Autosomal dominant polycystic kidney disease. Association strength is not clinical gene validity.
AVPR2: Vasopressin V2 receptor
A vasopressin receptor in kidney collecting-duct cells that activates cAMP signaling and promotes insertion of aquaporin-2 water channels. Pathogenic variants can cause X-linked nephrogenic diabetes insipidus.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in AVPR2 have source records linked to Autosomal dominant polycystic kidney disease. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Autosomal dominant polycystic kidney disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PKD2 R322W | 322 | Extracellular | Pathogenic / likely pathogenic (★★) |
| PKD2 R440S | 440 | Extracellular | Pathogenic / likely pathogenic (★★) |
| PKD2 Y345N | 345 | Extracellular | Pathogenic / likely pathogenic (★) |
| PKD2 R592P | 592 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| PKD2 Y368C | 368 | Extracellular | Pathogenic / likely pathogenic |
| PKD1 D3844H | 3844 | Extracellular | Pathogenic / likely pathogenic |
| PKD1 L93P | 93 | LRR 2 | Pathogenic / likely pathogenic |
| PKD1 C214S | 214 | WSC | Pathogenic / likely pathogenic |
| PKD1 S2131R | 2131 | PKD 17 | Pathogenic / likely pathogenic |
| PKD2 K688E | 688 | Cytoplasmic | Pathogenic / likely pathogenic |
| PKD1 D3204G | 3204 | PLAT | Pathogenic / likely pathogenic |
| PKD1 V1289M | 1289 | PKD 7 | Pathogenic / likely pathogenic |
Which prediction tools work for Autosomal dominant polycystic kidney disease
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 98 out of 100
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 95 out of 100
- EVE: 95 out of 100
- MetaSVM: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 93 out of 100
- MetaLR: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 91 out of 100
- PolyPhen-2: 79 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 76 out of 100
Same protein, different disease
- Polycystic kidney disease also has ClinVar records linked to PKD2 variants; they fall mostly in different places as the Autosomal dominant polycystic kidney disease variants (8 pathogenic / likely pathogenic).
- Polycystic kidney disease also has ClinVar records linked to PKD1 variants; they fall mostly in different places as the Autosomal dominant polycystic kidney disease variants (61 pathogenic / likely pathogenic).
Diseases related to Autosomal dominant polycystic kidney disease
- Polycystic kidney disease, also linked to PKD1 and PKD2
- Kidney disorder, also linked to PKD1 and PKD2
- Meckel syndrome, also linked to PKD1 and PKD2
- Nephrogenic diabetes insipidus, also linked to AVPR2
- Diabetes insipidus, nephrogenic, X-linked, also linked to AVPR2
- Renal tubulopathies, also linked to AVPR2
- Nephrogenic syndrome of inappropriate antidiuresis, also linked to AVPR2
Frequently asked questions
Which genes have records linked to Autosomal dominant polycystic kidney disease?
This view contains 3 analyzed proteins: PKD2, PKD1, AVPR2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 12 pathogenic or likely pathogenic variants, 356 variants of uncertain significance and 33 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 436 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center